Literature DB >> 4372409

Properties and location of poly(A) in Rous sarcoma virus RNA.

L H Wang, P Duesberg.   

Abstract

The poly(A) sequence of 30 to 40S Rous sarcoma virus RNA, prepared by digestion of the RNA with RNase T(1), showed a rather homogenous electrophoretic distribution in formamide-polyacrylamide gels. Its size was estimated to be about 200 AMP residues. The poly(A) appears to be located at or near the 3' end of the 30 to 40S RNA because: (i) it contained one adenosine per 180 AMP residues, and because (ii) incubation of 30 to 40S RNA with bacterial RNase H in the presence of poly(dT) removed its poly(A) without significantly affecting its hydrodynamic or electrophoretic properties in denaturing solvents. The viral 60 to 70S RNA complex was found to consist of 30 to 40S subunits both with (65%) and without (approximately 30%) poly(A). The heteropolymeric sequences of these two species of 30 to 40S subunits have the same RNase T(1)-resistant oligonucleotide composition. Some, perhaps all, RNase T(1)-resistant oligonucleotides of 30 to 40S Rous sarcoma virus RNA appear to have a unique location relative to the poly(A) sequence, because the complexity of poly(A)-tagged fragments of 30 to 40S RNA decreased with decreasing size of the fragment. Two RNase T(1)-resistant oligonucleotides which distinguish sarcoma virus Prague B RNA from that of a transformation-defective deletion mutant of the same virus appear to be associated with an 11S poly(A)-tagged fragment of Prague B RNA. Thus RNA sequences concerned with cell transformation seem to be located within 5 to 10% of the 3' terminus of Prague B RNA.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4372409      PMCID: PMC355682     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  The identification of the 3'-hydroxyl nucleoside terminus of avian myeloblastosis virus RNA.

Authors:  R L Erikson; E Erikson; T A Walker
Journal:  Virology       Date:  1971-08       Impact factor: 3.616

2.  Proteins of Rous sarcoma virus.

Authors:  P H Duesberg; H L Robinson; W S Robinson; R J Huebner; H C Turner
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

3.  Physical properties of Rous Sarcoma Virus RNA.

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

4.  The role of deoxyribonucleic acid in ribonucleic acid synthesis. XIV. A study of the initiation of ribonucleic acid synthesis.

Authors:  U Maitra; Y Nakata; J Hurwitz
Journal:  J Biol Chem       Date:  1967-11-10       Impact factor: 5.157

5.  Adenine-rich polymer associated with rabbit reticulocyte messenger RNA.

Authors:  L Lim; E S Canellakis
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  An artifact in the alkaline hydrolysis of RNA labeled with guanosine-8-T.

Authors:  F H Wilt
Journal:  Anal Biochem       Date:  1969-01       Impact factor: 3.365

7.  The isolation and characterization of adenosine monophosphate-rich polynucleotides synthesized by Ehrlich ascites cells.

Authors:  M Edmonds; M G Caramela
Journal:  J Biol Chem       Date:  1969-03-10       Impact factor: 5.157

8.  Replication of viral RNA. XV. Purification and properties of Q-beta minus strands.

Authors:  R Pollet; P Knolle; C Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

9.  A proton exchange between purines and water and its application to biochemistry.

Authors:  K R Shelton; J M Clark
Journal:  Biochemistry       Date:  1967-09       Impact factor: 3.162

10.  Messenger and heterogeneous nuclear RNA in HeLa cells: differential inhibition by cordycepin.

Authors:  S Penman; M Rosbash; M Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

View more
  42 in total

1.  Determination of the length distribution of poly(A) at the 3' terminus of the virion RNAs of EMC virus, poliovirus, rhinovirus, RAV-61 and CPMV and of mouse globin mRNA.

Authors:  P Ahlquist; P Kaesberg
Journal:  Nucleic Acids Res       Date:  1979-11-10       Impact factor: 16.971

2.  In vitro, the major ribosome binding site on Rous sarcoma virus RNA does not contain the nucleotide sequence coding for the N-terminal amino acids of the gag gene product.

Authors:  J L Darlix; P F Spahr; P A Bromley; J C Jaton
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

3.  Site on the RNA of an avian sarcoma virus at which primer is bound.

Authors:  J M Taylor; R Illmensee
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

4.  Genomic complexities of murine leukemia and sarcoma, reticuloendotheliosis, and visna viruses.

Authors:  K L Beemon; A J Faras; A T Hasse; P H Duesberg; J E Maisel
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

5.  RNA of replication-defective strains of Rous sarcoma virus.

Authors:  P H Duesberg; S Kawai; L H Wang; P K Vogt; H M Murphy; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

6.  Heteroduplex analysis of avian RNA tumor viruses.

Authors:  R P Junghans; S Hu; C A Knight; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

7.  Structure of 50 to 70S RNA from Moloney sarcoma viruses.

Authors:  J Maisel; W Bender; S Hu; P H Duesberg; N Davidson
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

8.  The "sarcoma-specific" region of Moloney murine sarcoma virus 124.

Authors:  D Dina
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

9.  Induction of tumors and generation of recovered sarcoma viruses by, and mapping of deletions in, two molecularly cloned src deletion mutants.

Authors:  L H Wang; B Edelstein; B J Mayer
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

10.  Molecular cloning and characterization of avian sarcoma virus UR2 and comparison of its transforming sequence with those of other avian sarcoma viruses.

Authors:  W S Neckameyer; L H Wang
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.